James McCarthy

James McCarthy

Directeur/Bestuurslid bij NOVACYT

58 jaar
Health Technology
Process Industries
Electronic Technology

Oorsprong van het eerstegraads netwerk van James McCarthy

EntiteitType entiteitIndustrie
Public Company Medical Specialties 20
4
Subsidiary Biotechnology 4

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met James McCarthy via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
Investment Managers

John Brown

Consultant / Advisor

Medical Specialties

Lyn Rees

Chief Executive Officer

VECTURA GROUP Pharmaceuticals: Major

John Brown

Juliet Thompson

Chairman

Director/Board Member

Medical Distributors

John Brown

Chairman

INDIVIOR PLC Pharmaceuticals: Major

Juliet Thompson

Director/Board Member

Investment Managers

James Christopher Wakefield

Director/Board Member

Pharmaceuticals: Major

Lyn Rees

Director/Board Member

Investment Managers

James Christopher Wakefield

Private Equity Investor

University of Wales (Bangor) College/University

Lyn Rees

Undergraduate Degree

Investment Managers

James Christopher Wakefield

Founder

Pharmaceuticals: Major

Lyn Rees

Director/Board Member

Medical/Nursing Services

Ed Snape

Graham David Mullis

James Christopher Wakefield

Director/Board Member

Chief Executive Officer

Chairman

Miscellaneous Commercial Services

Andrew Heath

John Brown

Director/Board Member

Director/Board Member

BIONOTE, INC. Medical Specialties

Lyn Rees

Chief Executive Officer

Investment Managers

John Brown

Private Equity Investor

Medical Specialties

James Christopher Wakefield

Director/Board Member

BBI Enzymes UK Ltd.

Lyn Rees

Director/Board Member

Motor Vehicles

Lyn Rees

Sales & Marketing

Electronic Equipment/Instruments

Graham David Mullis

Anthony Dyer

Director/Board Member

Director/Board Member

Electronic Equipment/Instruments

Juliet Thompson

Director/Board Member

Drugstore Chains

Lyn Rees

Director/Board Member

ABINGDON HEALTH PLC Medical Specialties

Lyn Rees

Director/Board Member

Medical Specialties

Lyn Rees

Founder

Harvard Business School College/University

James Christopher Wakefield

Undergraduate Degree

Medical/Nursing Services

John Brown

Lyn Rees

Chairman

Chief Executive Officer

Medical Specialties

Lyn Rees

Joanne Mason

Director/Board Member

Director/Board Member

YOURGENE HEALTH Medical Specialties

John Brown

Lyn Rees

Joanne Mason

Chairman

Chief Executive Officer

Chief Tech/Sci/R&D Officer

Scipac Ltd.

Lyn Rees

Director/Board Member

Miscellaneous Commercial Services

Lyn Rees

Director/Board Member

Pharmaceuticals: Major

David Allmond

Corporate Officer/Principal

BBI Acquisition Ltd. Finance/Rental/Leasing

Lyn Rees

Director/Board Member

MYHEALTHCHECKED PLC Medical Specialties

Lyn Rees

Director/Board Member

Chemicals: Specialty

Lyn Rees

Director/Board Member

Financial Conglomerates

Lyn Rees

Director/Board Member

Pharmaceuticals: Major

Lyn Rees

Founder

Financial Conglomerates

Graham David Mullis

Anthony Dyer

Chairman

Director of Finance/CFO

Financial Conglomerates

Lyn Rees

Director/Board Member

Miscellaneous Commercial Services

Lyn Rees

Director/Board Member

Medical Distributors

Lyn Rees

Chief Executive Officer

Chemicals: Major Diversified

Lyn Rees

Director/Board Member

Personnel Services

Lyn Rees

Director/Board Member

Packaged Software

Lyn Rees

Director/Board Member

Biotechnology

Lyn Rees

Director/Board Member

Pharmaceuticals: Other

John Brown

Director/Board Member

BBI Enzymes Ltd.

Lyn Rees

Director/Board Member

Statistieken

Internationaal

Verenigd Koninkrijk 46
Verenigde Staten 3
Canada 2
Zuid-Korea 2
Nederland 2

Sectoraal

Health Technology 18
Finance 11
Commercial Services 5
Distribution Services 4
Electronic Technology 4

Operationeel

Director/Board Member 107
Corporate Officer/Principal 33
Chairman 30
Independent Dir/Board Member 21
Chief Executive Officer 12
  1. Beurs
  2. Insiders
  3. James McCarthy
  4. Bedrijfsconnecties
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU